TheNote.app
Science Magazine | AAAS: Science Advances

Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine | Science Advances

AVX/COVID-12 vaccine is safe, immunogenic, and noninferior to AZ/ChAdOx-1-S in previously vaccinated and/or infected volunteers.
favicon
science.org
science.org
Image for the article: Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine | Science Advances
RSS Hunter
Create attached notes ...
© 2015-2025, TheNote.app
· Privacy Policy · Terms & Conditions · Contact · Android  iPhone  mac